A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in users administering products of uncertain source.
Several experts said the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Content Elimination
Based on the social media company, the service has removed violative material and banned associated keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
After moments of joining one group, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Information and Pricing
Within these groups, messages display black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant medical dangers”.
